- Home
- CBLL vs AMLX Comparison
CBLL vs AMLX Comparison
Compare CBLL & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBLL
- AMLX
- Stock Information
- Founded
- CBLL 2014
- AMLX 2014
- Country
- CBLL United States
- AMLX United States
- Employees
- CBLL N/A
- AMLX N/A
- Industry
- CBLL
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- CBLL
- AMLX Health Care
- Exchange
- CBLL Nasdaq
- AMLX Nasdaq
- Market Cap
- CBLL 710.2M
- AMLX 684.6M
- IPO Year
- CBLL 2024
- AMLX 2022
- Fundamental
- Price
- CBLL $14.14
- AMLX $7.72
- Analyst Decision
- CBLL Strong Buy
- AMLX Strong Buy
- Analyst Count
- CBLL 6
- AMLX 7
- Target Price
- CBLL $33.00
- AMLX $12.00
- AVG Volume (30 Days)
- CBLL 209.0K
- AMLX 1.5M
- Earning Date
- CBLL 08-05-2025
- AMLX 08-07-2025
- Dividend Yield
- CBLL N/A
- AMLX N/A
- EPS Growth
- CBLL N/A
- AMLX N/A
- EPS
- CBLL N/A
- AMLX N/A
- Revenue
- CBLL $71,535,000.00
- AMLX N/A
- Revenue This Year
- CBLL $33.98
- AMLX N/A
- Revenue Next Year
- CBLL $28.82
- AMLX N/A
- P/E Ratio
- CBLL N/A
- AMLX N/A
- Revenue Growth
- CBLL 44.86
- AMLX N/A
- 52 Week Low
- CBLL $10.01
- AMLX $1.76
- 52 Week High
- CBLL $32.75
- AMLX $8.72
- Technical
- Relative Strength Index (RSI)
- CBLL N/A
- AMLX 54.70
- Support Level
- CBLL N/A
- AMLX $7.84
- Resistance Level
- CBLL N/A
- AMLX $8.29
- Average True Range (ATR)
- CBLL 0.00
- AMLX 0.45
- MACD
- CBLL 0.00
- AMLX -0.13
- Stochastic Oscillator
- CBLL 0.00
- AMLX 2.90
About CBLL CeriBell Inc. Common Stock
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.